Quantamental Technologies LLC Puma Biotechnology, Inc. Transaction History

Quantamental Technologies LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$6.5 - $10.73 $82,855 - $136,775	-12,747 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$8.75 - $12.85 $73,228 - $107,541	8,369 Added 191.16%	12,747 $137,000
Q2 2019 Aug 12, 2019	BUY	$12.3 - $35.76 $53,849 - $156,557	4,378 New	4,378 $56,000
Q1 2019 Apr 29, 2019	SELL	$20.77 - $42.37 $114,318 - $233,204	-5,504 Closed	0 $0
Q4 2018 Jan 28, 2019	BUY	$20.07 - $46.7 $110,465 - $257,036	5,504 New	5,504 $112,000

29.4M

842K

32.2K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $164M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantamental Technologies LLC with notifications on news.